Abstract
A reduction in the mortality secondary to relapse, infections, graft versus host disease, and other acute transplant related complications is leading to improved survival rates and thus an ever-increasing population of hematopoietic cell transplant (HCT) survivors. For survivors of HCT during childhood, late effects can have a significant adverse impact on their overall functional outcomes and quality of life. This chapter will highlight what we are learning about long-term risks that may either be preventable with appropriate monitoring and screening or manageable with appropriate interventions. It is increasingly important that our long-term survivors be educated regarding their potential long-term risks and that they continue to receive periodic evaluations by providers who are knowledgeable regarding the unique issues that HCT survivors may face.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abboud I, Porcher R, Robin M, de Latour RP, Glotz D, Socie G, Peraldi MN (2009) Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 15(10):1251–1257
Aceves SS, Bastian JF, Newbury RO, Dohil R (2007) Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol 102(10):2271–2279
Afify Z, Shaw PJ, Clavano-Harding A, Cowell CT (2000) Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant 25(10):1087–1092. doi:10.1038/sj.bmt.1702384
Agarwala S, Jain D, Joshi VR, Sule A (2005) Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study [erratum appears in Rheumatology (Oxford). 2005 Apr;44(4):569]. Rheumatology 44(3):352–359
Akar H, Keven K, Celebi H, Orhan D, Nergizoglu G, Erbay B, Tulunay O, Ozcan M, Erturk S (2002) Nephrotic syndrome after allogeneic peripheral blood stem cell transplantation. J Nephrol 15(1):79–82
Akpek G, Valladares JL, Lee L, Margolis J, Vogelsang GB (2001) Pancreatic insufficiency in patients with chronic graft-versus-host disease. Bone Marrow Transplant 27(2):163–166
Akpek G, Chinratanalab W, Lee LA, Torbenson M, Hallick JP, Anders V, Vogelsang GB (2003) Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study. Biol Blood Marrow Transplant 9(1):46–51
Ali S, Pimentel JD, Munoz J, Shah V, McKinnon R, Divine G, Janakiraman N (2012) Iron overload in allogeneic hematopoietic stem cell transplant recipients. Arch Pathol Lab Med 136(5):532–538
Altes A, Remacha AF, Sureda A, Martino R, Briones J, Canals C, Brunet S, Sierra J, Gimferrer E (2002) Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant 29(12):987–989
Anserini P, Chiodi S, Spinelli S, Costa M, Conte N, Copello F, Bacigalupo A (2002) Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling. Bone Marrow Transplant 30(7):447–451. doi:10.1038/sj.bmt.1703651
Aristei C, Alessandro M, Santucci A, Aversa F, Tabillo A, Carotti A, Latini RA, Cagini C, Latini P (2002) Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation. Bone Marrow Transplant 29(6):503–507
Arlet J (1992) Nontraumatic avascular necrosis of the femoral head. Past, present, and future (Review). Clin Orthop Relat Res 277:12–21
Armand P, Kim HT, Rhodes J, Sainvil MM, Cutler C, Ho VT, Koreth J, Alyea EP, Hearsey D, Neufeld EJ, Fleming MD, Steen H, Anderson D, Kwong RY, Soiffer RJ, Antin JH (2011) Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation. Biol Blood Marrow Transplant 17(6):852–860
Armand P, Sainvil MM, Kim HT, Rhodes J, Cutler C, Ho VT, Koreth J, Alyea EP, Neufeld EJ, Kwong RY, Soiffer RJ, Antin JH (2012) Does iron overload really matter in stem cell transplantation? Am J Hematol 87(6):569–572
Armenian SH, Sun CL, Kawashima T, Arora M, Leisenring W, Sklar CA, Baker KS, Francisco L, Teh JB, Mills G, Wong FL, Rosenthal J, Diller LR, Hudson MM, Oeffinger KC, Forman SJ, Robison LL, Bhatia S (2011) Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood 118(5):1413–1420. doi:10.1182/blood-2011-01-331835, blood-2011-01-331835 [pii]
Atkinson SA, Halton JM, Bradley C, Wu B, Barr RD (1998) Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition. Int J Cancer Suppl 11:35–39
Atree SV, Crilley PA, Conroy JF, Micaily B, Brodsky JT (1995) Cancer of the esophagus following allogeneic bone marrow transplantation for acute leukemia. Am J Clin Oncol 18(4):343–347
Au WY, Ma ES, Lee TL, Ha SY, Fung AT, Lie AK, Kwong YL (2007) Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab. Br J Haematol 137(5):475–478
Bae SJ, Kang C, Sung KW, Chueh HW, Son MH, Lee SH, Yoo KH, Koo HH (2012) Iron Overload during Follow-up after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma. J Korean Med Sci 27(4):363–369
Baek KH, Lee WY, Oh KW, Kim HS, Han JH, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim CC (2004) Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism. J Clin Endocrinol Metab 89(3):1246–1254
Bagesund M, Richter S, Agren B, Ringden O, Dahllof G (2000a) Scintigraphic study of the major salivary glands in pediatric bone marrow transplant recipients. Bone Marrow Transplant 26(7):775–779
Bagesund M, Winiarski J, Dahllof G (2000b) Subjective xerostomia in long-term surviving children and adolescents after pediatric bone marrow transplantation. Transplantation 69(5):822–826
Bai HX, Ma MH, Orabi AI, Park A, Latif SU, Bhandari V, Husain SZ (2011) Novel characterization of drug-associated pancreatitis in children. J Pediatr Gastroenterol Nutr 53(4):423–428
Bailey HK, Kappy MS, Giller RH, Gralla J (2008) Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation. Pediatr Blood Cancer 51(3):405–409. doi:10.1002/pbc.21634
Baim S, Leonard MB, Bianchi ML, Hans DB, Kalkwarf HJ, Langman CB, Rauch F (2008) Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom 11(1):6–21. doi:10.1016/j.jocd.2007.12.002, S1094-6950(07)00250-8 [pii]
Baker KS, DeFor TE, Burns LJ, Ramsay NK, Neglia JP, Robison LL (2003) New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol 21(7):1352–1358
Baker KS, Gurney JG, Ness KK, Bhatia R, Forman SJ, Francisco L, McGlave PB, Robison LL, Snyder DS, Weisdorf DJ, Bhatia S (2004) Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood 104(6):1898–1906. doi:10.1182/blood-2004-03-1010, 2004-03-1010 [pii]
Baker KS, Ness KK, Steinberger J, Carter A, Francisco L, Burns LJ, Sklar C, Forman S, Weisdorf D, Gurney JG, Bhatia S (2007) Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood 109(4):1765–1772. doi:10.1182/blood-2006-05-022335, blood-2006-05-022335 [pii]
Baker KS, Steffen L, Zhou X, Kelly A, Lee JM, Petryk A, Sinaiko AR, Dengel DR, Mulrooney DA, Steinberger J (2009) Total body irradiation (TBI) increases cardio-metabolic risk and induces carotid vascular stiffness in survivors after hematopoietic cell transplant (HCT) for childhood hematologic malignancies. Blood 114(22):1291
Balasubramaniam R, Alawi F, DeRossi S (2009) Superficial mucoceles in chronic graft-versus-host disease: a case report and review of the literature. Gen Dent 57(1):82–88
Banfi A, Podesta M, Fazzuoli L, Sertoli MR, Venturini M, Santini G, Cancedda R, Quarto R (2001) High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia. Cancer 92(9):2419–2428, 10.1002/1097-0142(20011101)92:9 < 2419::AID-CNCR1591 > 3.0.CO;2-K [pii]
Barrera M, Atenafu E (2008) Cognitive, educational, psychosocial adjustment and quality of life of children who survive hematopoietic SCT and their siblings. Bone Marrow Transplant 42(1):15–21. doi:10.1038/bmt.2008.84, bmt200884 [pii]
Barrera M, Atenafu E, Andrews GS, Saunders F (2008) Factors related to changes in cognitive, educational and visual motor integration in children who undergo hematopoietic stem cell transplant. J Pediatr Psychol 33(5):536–546. doi:10.1093/jpepsy/jsm080, jsm080 [pii]
Batts ED, Lazarus HM (2007) Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting? Bone Marrow Transplant 40(8):709–719
Benyunes MC, Sullivan KM, Deeg HJ, Mori M, Meyer W, Fisher L, Bensinger R, Jack MK, Hicks J, Witherspoon R, Buckner CD, Hansen JA, Appelbaum FR, Storb R (1995) Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation. Int J Radiat Oncol Biol Phys 32(3):661–670
Berg U, Bolme P (1989) Renal function in children following bone marrow transplantation. Transplant Proc 21(1 Pt 3):3092–3094
Berger C, Le-Gallo B, Donadieu J, Richard O, Devergie A, Galambrun C, Bordigoni P, Vilmer E, Plouvier E, Perel Y, Michel G, Stephan JL (2005) Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant 35(10):991–995. doi:10.1038/sj.bmt.1704945, 1704945 [pii]
Bhatia S, Robison LL, Francisco L, Carter A, Liu Y, Grant M, Baker KS, Fung H, Gurney JG, McGlave PB, Nademanee A, Ramsay NK, Stein A, Weisdorf DJ, Forman SJ (2005) Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood 105(11):4215–4222. doi:10.1182/blood-2005-01-0035, 2005-01-0035 [pii]
Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG, McGlave PB, Nademanee A, O'Donnell M, Ramsay NK, Robison LL, Snyder D, Stein A, Forman SJ, Weisdorf DJ (2007) Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 110(10):3784–3792. doi:10.1182/blood-2007-03-082933, blood-2007-03-082933 [pii]
Bishop N, Braillon P, Burnham J, Cimaz R, Davies J, Fewtrell M, Hogler W, Kennedy K, Makitie O, Mughal Z, Shaw N, Vogiatzi M, Ward K, Bianchi ML (2008) Dual-energy X-ray absorptiometry assessment in children and adolescents with diseases that may affect the skeleton: the 2007 ISCD Pediatric Official Positions. J Clin Densitom 11(1):29–42. doi:10.1016/j.jocd.2007.12.004, S1094-6950(07)00252-1 [pii]
Bobak D, Arfons LM, Creger RJ, Lazarus HM (2008) Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? Bone Marrow Transplant 42(11): 705–713
Borgmann A, Zinn C, Hartmann R, Herold R, Kaatsch P, Escherich G, Moricke A, Henze G, von Stackelberg A (2008) Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood. Eur J Cancer 44(2):257–268
Borgstrom B, Bolme P (1994) Thyroid function in children after allogeneic bone marrow transplantation. Bone Marrow Transplant 13(1):59–64
Boulad F, Bromley M, Black P, Heller G, Sarafoglou K, Gillio A, Papadopoulos E, Sklar C (1995) Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant 15(1):71–76
Bozzola M, Giorgiani G, Locatelli F, Cisternino M, Gambarana D, Zecca M, Torcetta F, Severi F (1993) Growth in children after bone marrow transplantation. Horm Res 39(3–4):122–126
Brand HS, Bots CP, Raber-Durlacher JE (2009) Xerostomia and chronic oral complications among patients treated with haematopoietic stem cell transplantation. Br Dent J 207(9):E17, discussion 428–429
Brauner R, Fontoura M, Zucker JM, Devergie A, Souberbielle JC, Prevot-Saucet C, Michon J, Gluckman E, Griscelli C, Fischer A et al (1993) Growth and growth hormone secretion after bone marrow transplantation. Arch Dis Childhood 68(4):458–463
Brauner R, Adan L, Souberbielle JC, Esperou H, Michon J, Devergie A, Gluckman E, Zucker JM (1997) Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr 130(5):785–792, S0022-3476(97)80022-4 [pii]
Bray LC, Carey PJ, Proctor SJ, Evans RG, Hamilton PJ (1991) Ocular complications of bone marrow transplantation. Br J Ophthalmol 75(10):611–614
Brittenham GM, Badman DG (2003) Noninvasive measurement of iron: report of an NIDDK workshop. Blood 101(1):15–19
Brukamp K, Doyle AM, Bloom RD, Bunin N, Tomaszewski JE, Cizman B (2006) Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease? Clin J Am Soc Nephrol 1(4):685–694
Busca A, Uderzo C (2000) BMT: Bone Marrow Transplant Associated Thrombotic Microangiopathy. Hematology 5(1):53–67
Bushhouse S, Ramsay NK, Pescovitz OH, Kim T, Robison LL (1989) Growth in children following irradiation for bone marrow transplantation. Am J Pediat Hematol/Oncol 11(2):134–140
Butcher JA, Hariharan S, Adams MB, Johnson CP, Roza AM, Cohen EP (1999) Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression. Clin Transplant 13(4):330–335
Calissendorff BM, Bolme P (1993) Cataract development and outcome of surgery in bone marrow transplanted children. Br J Ophthalmol 77(1):36–38
Campbell J, Moravec C (2008) Long term complications of hematopoietic stem cell transplantation. Stem cell transplantation clinical textbook. Oncology Nursing Press, Pittsburgh
Carella AM, D'Arena G, Greco MM, Nobile M, Cascavilla N (2008) Rituximab for allo-SCT-associated thrombotic thrombocytopenic purpura. Bone Marrow Transplant 41(12):1063–1065
Carlson K, Simonsson B, Ljunghall S (1994) Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism. Calcif Tissue Int 55(6):408–411
Carneiro AA, Fernandes JP, de Araujo DB, Elias J Jr, Martinelli AL, Covas DT, Zago MA, Angulo IL, St Pierre TG, Baffa O (2005) Liver iron concentration evaluated by two magnetic methods: magnetic resonance imaging and magnetic susceptometry. Magn Reson Med 54(1):122–128
Carpenter PA, Hoffmeister P, Chesnut CH 3rd, Storer B, Charuhas PM, Woolfrey AE, Sanders JE (2007) Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease. Biol Blood Marrow Transplant 13(6):683–690. doi:10.1016/j.bbmt.2007.02.001, S1083-8791(07)00146-2 [pii]
Carter A, Robison LL, Francisco L, Smith D, Grant M, Baker KS, Gurney JG, McGlave PB, Weisdorf DJ, Forman SJ, Bhatia S (2006) Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant 37(11):1023–1029. doi:10.1038/sj.bmt.1705364, 1705364 [pii]
Castaneda S, Carmona L, Carvajal I, Arranz R, Diaz A, Garcia-Vadillo A (1997) Reduction of bone mass in women after bone marrow transplantation. Calcif Tissue Int 60(4):343–347
Castro FP Jr, Barrack RL (2000) Core decompression and conservative treatment for avascular necrosis of the femoral head: a meta-analysis. Am J Orthop (Chatham, NJ) 29(3):187–194
Chae YS, Kim JG, Moon JH, Kim SN, Lee SJ, Kim YJ, Sohn SK (2009) Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients. Bone Marrow Transplant 44(1):35–41. doi:10.1038/bmt.2008.414, bmt2008414 [pii]
Chan GS, Lam MF, Au WY, Tse KC, Chan TM, Lai KN, Chan KW (2004) IgA nephropathy complicating graft-versus-host disease, another nephropathy causing nephrotic syndrome after bone marrow transplantation. Histopathology 45(6):648–651
Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR (2009) Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol 4(2):345–353
Cherqui D, Rahmouni A, Charlotte F, Boulahdour H, Metreau JM, Meignan M, Fagniez PL, Zafrani ES, Mathieu D, Dhumeaux D (1995) Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 22(6):1674–1681
Choi CM, Schmaier AH, Snell MR, Lazarus HM (2009) Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment. Drugs 69(2):183–198
Chotsampancharoen T, Gan K, Kasow KA, Barfield RC, Hale GA, Leung W (2009) Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation. Pediatr Transplant 13(3):348–352
Clark WF (2012) Plasma exchange for renal disease: Evidence and use 2011. J Clin Apher 27(3):112–116. doi:10.1002/jca.21221
Clarke SA, Eiser C, Skinner R (2008) Health-related quality of life in survivors of BMT for paediatric malignancy: a systematic review of the literature. Bone Marrow Transplant 42(2):73–82. doi:10.1038/bmt.2008.156, bmt2008156 [pii]
Clement-De Boers A, Oostdijk W, Van Weel-Sipman MH, Van den Broeck J, Wit JM, Vossen JM (1996) Final height and hormonal function after bone marrow transplantation in children. J Pediatr 129(4):544–550
Cohen A, Rovelli A, Van-Lint MT, Uderzo C, Morchio A, Pezzini C, Masera G, Bacigalupo A, Romano C (1996) Final height of patients who underwent bone marrow transplantation during childhood. Arch Dis Childhood 74(5):437–440
Cohen EP, Piering WF, Kabler-Babbitt C, Moulder JE (1998) End-stage renal disease (ESRD)after bone marrow transplantation: poor survival compared to other causes of ESRD. Nephron 79(4):408–412
Cohen A, Rovelli A, Bakker B, Uderzo C, van Lint MT, Esperou H, Gaiero A, Leiper AD, Dopfer R, Cahn JY, Merlo F, Kolb HJ, Socie G (1999) Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT. Blood 93(12):4109–4115
Cohen A, Rovelli A, van Lint MT, Merlo F, Gaiero A, Mulas R, Balduzzi A, Corti P, Uderzo C, Bacigalupo A (2001) Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood. Bone Marrow Transplant 28(12):1125–1128. doi:10.1038/sj.bmt.1703290
Cohen A, Rovelli A, Merlo DF, van Lint MT, Lanino E, Bresters D, Ceppi M, Bocchini V, Tichelli A, Socie G (2007) Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study. J Clin Oncol 25(17):2449–2454. doi:10.1200/JCO.2006.08.9276, 25/17/2449 [pii]
Couriel D, Carpenter PA, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J, Shaughnessy P, Hymes S, Kim S, Wayne AS, Chien JW, Neumann J, Mitchell S, Syrjala K, Moravec CK, Abramovitz L, Liebermann J, Berger A, Gerber L, Schubert M, Filipovich AH, Weisdorf D, Schubert MM, Shulman H, Schultz K, Mittelman B, Pavletic S, Vogelsang GB, Martin PJ, Lee SJ, Flowers MED (2006) Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group report. Biol Blood Marrow Transplant 12(4):375–396
Cruz DN, Perazella MA, Mahnensmith RL (1997) Bone marrow transplant nephropathy: a case report and review of the literature. J Am Soc Nephrol 8(1):166–173
Cummings SR, Bates D, Black DM (2002) Clinical use of bone densitometry: scientific review. JAMA 288(15):1889–1897, jsr20013 [pii]
Curtis RE, Metayer C, Rizzo JD, Socie G, Sobocinski KA, Flowers ME, Travis WD, Travis LB, Horowitz MM, Deeg HJ (2005) Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case–control study. Blood 105(10):3802–3811
Cutler C, Henry NL, Magee C, Li S, Kim HT, Alyea E, Ho V, Lee SJ, Soiffer R, Antin JH (2005) Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11(7):551–557
Dahllof G (1998) Craniofacial growth in children treated for malignant diseases. Acta Odontol Scand 56(6):378–382
Dahllof G, Barr M, Bolme P, Modeer T, Lonnqvist B, Ringden O, Heimdahl A (1988) Disturbances in dental development after total body irradiation in bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol 65(1):41–44
Dahllof G, Rozell B, Forsberg CM, Borgstrom B (1994) Histologic changes in dental morphology induced by high dose chemotherapy and total body irradiation. Oral Surg Oral Med Oral Pathol 77(1):56–60
Dahllof G, Bagesund M, Remberger M, Ringden O (1997a) Risk factors for salivary dysfunction in children 1 year after bone marrow transplantation. Oral Oncol 33(5):327–331
Dahllof G, Bagesund M, Ringden O (1997b) Impact of conditioning regimens on salivary function, caries-associated microorganisms and dental caries in children after bone marrow transplantation. A 4-year longitudinal study. Bone Marrow Transplant 20(6):479–483
Damewood MD, Grochow LB (1986) Prospects for fertility after chemotherapy or radiation for neoplastic disease. Fertil Steril 45(4):443–459
Daniels MW, Wilson DM, Paguntalan HG, Hoffman AR, Bachrach LK (2003) Bone mineral density in pediatric transplant recipients. Transplantation 76(4):673–678
Deeg HJ, Flournoy N, Sullivan KM, Sheehan K, Buckner CD, Sanders JE, Storb R, Witherspoon RP, Thomas ED (1984) Cataracts after total body irradiation and marrow transplantation: a sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys 10(7):957–964
Deeg HJ, Leisenring W, Storb R, Nims J, Flowers ME, Witherspoon RP, Sanders J, Sullivan KM (1998) Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 91(10):3637–3645
Demarosi F, Lodi G, Carrassi A, Soligo D, Sardella A (2005a) Oral malignancies following HSCT: graft versus host disease and other risk factors. Oral Oncol 41(9):865–877
Demarosi F, Soligo D, Lodi G, Moneghini L, Sardella A, Carrassi A (2005b) Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100(1):63–69
Dignan FL, Scarisbrick JJ, Cornish J, Clark A, Amrolia P, Jackson G, Mahendra P, Taylor PC, Shah P, Lightman S, Fortune F, Kibbler C, Andreyev J, Albanese A, Hadzic N, Potter MN, Shaw BE (2012) Organ-specific management and supportive care in chronic graft-versus-host disease. Br J Haematol 158(1):62–78
Dunn JP, Jabs DA, Wingard J, Enger C, Vogelsang G, Santos G (1993) Bone marrow transplantation and cataract development. Arch Ophthalmol 111(10):1367–1373
Dvorak CC, Wright NB, Wong WB, Kristovich KM, Matthews EW, Weinberg KI, Amylon MD, Agarwal R (2008) Safety of hematopoietic stem cell transplantation in children less than three years of age. Pediatr Hematol Oncol 25(8):705–722. doi:10.1080/08880010802243524, 906490039 [pii]
Dvorak CC, Gracia CR, Sanders JE, Cheng EY, Baker KS, Pulsipher MA, Petryk A (2011) NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks. Biol Blood Marrow Transplant 17(12):1725–1738. doi:10.1016/j.bbmt.2011.10.006, S1083-8791(11)00409-5 [pii]
Ebeling PR, Thomas DM, Erbas B, Hopper JL, Szer J, Grigg AP (1999) Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Miner Res 14(3):342–350
Fahnehjelm KT, Tornquist AL, Olsson M, Winiarski J (2007) Visual outcome and cataract development after allogeneic stem-cell transplantation in children. Acta Ophthalmol Scand 85(7):724–733
Fahnehjelm KT, Tornquist AL, Winiarski J (2008) Dry-eye syndrome after allogeneic stem-cell transplantation in children. Acta Ophthalmol 86(3):253–258
Faraci M, Bekassy AN, De Fazio V, Tichelli A, Dini G (2008) Non-endocrine late complications in children after allogeneic haematopoietic SCT. Bone Marrow Transplant 41(Suppl 2):S49–S57. doi:10.1038/bmt.2008.55, bmt200855 [pii]
Fehr T, Kahlert C, Fierz W, Joller-Jemelka HI, Riesen WF, Rickli H, Wuthrich RP, Ammann P (2004) Statin-induced immunomodulatory effects on human T cells in vivo. Atherosclerosis 175(1):83–90
Fink JC, Leisenring WM, Sullivan KM, Sherrard DJ, Weiss NS (1998) Avascular necrosis following bone marrow transplantation: a case–control study. Bone 22:67–71
Fletcher BD, Crom DB, Krance RA, Kun LE (1994) Radiation-induced bone abnormalities after bone marrow transplantation for childhood leukemia. Radiology 191(1):231–235
Fogo AB (2000) The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis. Am J Kidney Dis 35(2):179–188
Frisk P, Hagberg H, Mandahl A, Soderberg P, Lonnerholm G (2000) Cataracts after autologous bone marrow transplantation in children. Acta Paediatr 89(7):814–819
Frisk P, Bratteby LE, Carlson K, Lonnerholm G (2002) Renal function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant 29(2):129–136
Frisk P, Arvidson J, Gustafsson J, Lonnerholm G (2004) Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant 33(2):205–210. doi:10.1038/sj.bmt.1704324
Frisk P, Arvidson J, Ljunggren O, Gustafsson J (2011) Decreased bone mineral density in young adults treated with SCT in childhood: the role of 25-hydroxyvitamin D. Bone Marrow Transplant. doi:10.1038/bmt.2011.147, bmt2011147 [pii]
Fuge R, Bird JM, Fraser A, Hart D, Hunt L, Cornish JM, Goulden N, Oakhill A, Pamphilon DH, Steward CG, Marks DI (2001) The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation. Br J Haematol 113(1):58–64
Gallagher G, Forrest DL (2007) Second solid cancers after allogeneic hematopoietic stem cell transplantation. Cancer 109(1):84–92
Galotto M, Berisso G, Delfino L, Podesta M, Ottaggio L, Dallorso S, Dufour C, Ferrara GB, Abbondandolo A, Dini G, Bacigalupo A, Cancedda R, Quarto R (1999) Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol 27(9):1460–1466
Gaziev D, Baronciani D, Galimberti M, Polchi P, Angelucci E, Giardini C, Muretto P, Perugini S, Riggio S, Ghirlanda S, Erer B, Maiello A, Lucarelli G (1996) Mucormycosis after bone marrow transplantation: report of four cases in thalassemia and review of the literature. Bone Marrow Transplant 17(3):409–414
Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, Jaspers MW, Koning CC, Oldenburger F, Langeveld NE, Hart AA, Bakker PJ, Caron HN, van Leeuwen FE (2007) Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 297(24):2705–2715. doi:10.1001/jama.297.24.2705, 297/24/2705 [pii]
Giorgiani G, Bozzola M, Locatelli F, Picco P, Zecca M, Cisternino M, Dallorso S, Bonetti F, Dini G, Borrone C et al (1995) Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 86(2):825–831
Goldberg RJ, Nakagawa T, Johnson RJ, Thurman JM (2010) The role of endothelial cell injury in thrombotic microangiopathy. Am J Kidney Dis 56(6): 1168–1174
Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, Martin PJ, Sandmaier BM, Marr KA, Appelbaum FR, Storb R, McDonald GB (2010) Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 363(22):2091–2101. doi:10.1056/NEJMoa1004383
Gordon CM, Bachrach LK, Carpenter TO, Crabtree N, El-Hajj Fuleihan G, Kutilek S, Lorenc RS, Tosi LL, Ward KA, Ward LM, Kalkwarf HJ (2008) Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions. J Clin Densitom 11(1):43–58. doi:10.1016/j.jocd.2007.12.005, S1094-6950(07)00253-3 [pii]
Grigg AP, Bhathal PS (2001) Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients. Pathology 33(1):44–49
Grigg AP, Angus PW, Hoyt R, Szer J (2003) The incidence, pathogenesis and natural history of steatorrhea after bone marrow transplantation. Bone Marrow Transplant 31(8):701–703
Grigg AP, Shuttleworth P, Reynolds J, Schwarer AP, Szer J, Bradstock K, Hui C, Herrmann R, Ebeling PR (2006) Pamidronate reduces bone loss after allogeneic stem cell transplantation. J Clin Endocrinol Metab 91(10):3835–3843. doi:10.1210/jc.2006-0684, jc.2006-0684 [pii]
Gronroos MH, Bolme P, Winiarski J, Berg UB (2007) Long-term renal function following bone marrow transplantation. Bone Marrow Transplant 39(11):717–723
Gungor I, Schor K, Rosenthal P, Jacobs DS (2008) The Boston Scleral Lens in the treatment of pediatric patients. J AAPOS 12(3):263–267. doi:10.1016/j.jaapos.2007.11.008, S1091-8531(07)00546-0 [pii]
Gurgan C, Ozcan M, Karakus O, Zincircioglu G, Arat M, Soydan E, Topcuoglu P, Gurman G, Bostanci H (2012) Periodontal status and post-transplantation complications following intensive periodontal treatment in patients underwent allogenic hematopoietic stem cell transplantation conditioned with myeloablative regimen. Int J Dent Hyg 11(2):84–90
Hamon MD, Gale RF, Macdonald ID, Smith OP, Collis CH, Skeggs DB, Gandhi L, Prentice HG (1993) Incidence of cataracts after single fraction total body irradiation: the role of steroids and graft versus host disease. Bone Marrow Transplant 12(3):233–236
Harder H, Van Gool AR, Duivenvoorden HJ, Cornelissen JJ, Eijkenboom WM, Barge RM, van den Bent MJ (2007) Case-referent comparison of cognitive functions in patients receiving haematopoietic stem-cell transplantation for haematological malignancies: two-year follow-up results. Eur J Cancer 43(14):2052–2059. doi:10.1016/j.ejca.2007.06.005, S0959-8049(07)00486-8 [pii]
Hingorani S (2006) Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. J Am Soc Nephrol 17(7):1995–2005
Hingorani S (2008) Chronic kidney disease after pediatric hematopoietic cell transplant. Biol Blood Marrow Transplant 14(1 Suppl 1):84–87
Hingorani S, Guthrie KA, Schoch G, Weiss NS, McDonald GB (2007) Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 39(4):223–229
Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, Ferrara J, Soiffer R, Giralt S (2005) Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11(8):571–575
Hoffmeister PA, Storer BE, Sanders JE (2004) Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation. J Pediatr Hematol Oncol 26(2):81–90
Holdaas H, Fellstrom B, Jardine AG, Holme I, Nyberg G, Fauchald P, Gronhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambuhl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR, Assessment of LiRTSI (2003) Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 361(9374):2024–2031
Holmstrom G, Borgstrom B, Calissendorff B (2002) Cataract in children after bone marrow transplantation: relation to conditioning regimen. Acta Ophthalmol Scand 80(2):211–215
Holtta P, Hovi L, Saarinen-Pihkala UM, Peltola J, Alaluusua S (2005) Disturbed root development of permanent teeth after pediatric stem cell transplantation. Dental root development after SCT. Cancer 103(7):1484–1493
Howell SJ, Shalet SM (2005) Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 34:12–17. doi:10.1093/jncimonographs/lgi003, 2005/34/12 [pii]
Huma Z, Boulad F, Black P, Heller G, Sklar C (1995) Growth in children after bone marrow transplantation for acute leukemia. Blood 86(2):819–824
Imanguli MM, Pavletic SZ, Guadagnini JP, Brahim JS, Atkinson JC (2006) Chronic graft versus host disease of oral mucosa: review of available therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(2):175–183
Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP (2007) Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 5(8):938–945, 945, e931–934
Ishiguro H, Yasuda Y, Tomita Y, Shinagawa T, Shimizu T, Morimoto T, Hattori K, Matsumoto M, Inoue H, Yabe H, Yabe M, Shinohara O, Kato S (2004) Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J Clin Endocrinol Metab 89(12):5981–5986. doi:10.1210/jc.2004-0836, 89/12/5981 [pii]
Jacobs SR, Small BJ, Booth-Jones M, Jacobsen PB, Fields KK (2007) Changes in cognitive functioning in the year after hematopoietic stem cell transplantation. Cancer 110(7):1560–1567. doi:10.1002/cncr.22962
Jastaniah W, Harmatz P, Pakbaz Z, Fischer R, Vichinsky E, Walters MC (2008) Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies. Pediatr Blood Cancer 50(2):319–324
Jones LR, Toth BB, Keene HJ (1992) Effects of total body irradiation on salivary gland function and caries-associated oral microflora in bone marrow transplant patients. Oral Surg Oral Med Oral Pathol 73(6):670–676
Jurges E, el Tumi M, O'Donohue J, Hobbs J (1991) Pancreatic insufficiency after bone-marrow transplantation. Lancet 338(8765):517
Kamble RT, Chang CC, Sanchez S, Carrum G (2007) Central nervous system graft-versus-host disease: report of two cases and literature review. Bone Marrow Transplant 39(1):49–52
Kami M, Tanaka Y, Chiba S, Matsumura T, Machida U, Kanda Y, Nakagawa K, Mitsuhashi T, Hirai H (2001) Thyroid function after bone marrow transplantation: possible association between immune-mediated thyrotoxicosis and hypothyroidism. Transplantation 71(3):406–411
Kananen K, Volin L, Laitinen K, Alfthan H, Ruutu T, Valimaki MJ (2005) Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J Clin Endocrinol Metab 90(7):3877–3885. doi:10.1210/jc.2004-2161, jc.2004-2161 [pii]
Kanda J, Kawabata H, Chao NJ (2011) Iron overload and allogeneic hematopoietic stem-cell transplantation. Expert Rev Hematol 4(1):71–80
Kang MI, Lee WY, Oh KW, Han JH, Song KH, Cha BY, Lee KW, Son HY, Kang SK, Kim CC (2000) The short-term changes of bone mineral metabolism following bone marrow transplantation. Bone 26(3):275–279
Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ 3rd, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42(3):467–475. doi:10.1016/j.bone.2007.11.001, S8756-3282(07)00823-X [pii]
Kaste SC, Shidler TJ, Tong X, Srivastava DK, Rochester R, Hudson MM, Shearer PD, Hale GA (2004) Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant 33(4):435–441
Kaste SC, Goodman P, Leisenring W, Stovall M, Hayashi RJ, Yeazel M, Beiraghi S, Hudson MM, Sklar CA, Robison LL, Baker KS (2009) Impact of radiation and chemotherapy on risk of dental abnormalities: a report from the Childhood Cancer Survivor Study. Cancer 115(24):5817–5827
Katsanis E, Shapiro RS, Robison LL, Haake RJ, Kim T, Pescovitz OH, Ramsay NK (1990) Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients. Bone Marrow Transplant 5(5):335–340
Kersting S, Hene RJ, Koomans HA, Verdonck LF (2007a) Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 13(10):1169–1175
Kersting S, Koomans HA, Hene RJ, Verdonck LF (2007b) Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival. Bone Marrow Transplant 39(6):359–365
Khoshniat M, Ghavamzadeh A, Larijani B, Bahar B, Tabatabaei O (2003) Effect on growth parameters of bone marrow transplantation with a chemotherapy-only conditioning regimen. Transplant Proc 35(8):3085–3088, S0041134503011266 [pii]
Kim YR, Kim JS, Cheong JW, Song JW, Min YH (2008) Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies. Acta Haematol 120(3):182–189
Kim JY, Lee MY, Kim B, Park CW, Chang YS, Chung S (2010) Membranoproliferative glomerulonephritis following allogeneic hematopoietic stem cell transplantation. Clin Exp Nephrol 14(6):630–632
Kist-van Holthe JE, van Zwet JM, Brand R, van Weel MH, Vossen JM, van der Heijden AJ (1998) Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 22(6):559–564
Koc S, Leisenring W, Flowers MED, Anasetti C, Deeg HJ, Nash RA, Sanders JE, Witherspoon RP, Storb R, Appelbaum FR, Martin PJ (2002) Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood 100(1):48–51
Kolb HJ, Socie G, Duell T, Van Lint MT, Tichelli A, Apperley JF, Nekolla E, Ljungman P, Jacobsen N, van Weel M, Wick R, Weiss M, Prentice HG (1999) Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med 131(10):738–744, 199911160–00004 [pii]
Kontoyiannis DP, Chamilos G, Lewis RE, Giralt S, Cortes J, Raad II, Manning JT, Han X (2007) Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer 110(6):1303–1306
Koo KH, Kim R, Ko GH, Song HR, Jeong ST, Cho SH (1995) Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression. J Bone Joint Surg Br Vol 77(6):870–874
Kramer JH, Crittenden MR, DeSantes K, Cowan MJ (1997) Cognitive and adaptive behavior 1 and 3 years following bone marrow transplantation. Bone Marrow Transplant 19(6):607–613. doi:10.1038/sj.bmt.1700699
Kremer LC, van Dalen EC, Offringa M, Voute PA (2002a) Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Ann Oncol 13(4):503–512
Kremer LC, van der Pal HJ, Offringa M, van Dalen EC, Voute PA (2002b) Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol 13(6):819–829
Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM (2005) The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am Vol 87(10):2155–2159
Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288(21): 2709–2716
Laporte S, Couto-Silva AC, Trabado S, Lemaire P, Brailly-Tabard S, Esperou H, Michon J, Baruchel A, Fischer A, Trivin C, Brauner R (2011) Inhibin B and anti-Mullerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood. BMC Pediatr 11:20. doi:10.1186/1471-2431-11-20, 1471-2431-11-20 [pii]
Laskin BL, Goebel J, Davies SM, Jodele S (2011) Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 118(6):1452–1462
Lawton CA, Cohen EP, Barber-Derus SW, Murray KJ, Ash RC, Casper JT, Moulder JE (1991) Late renal dysfunction in adult survivors of bone marrow transplantation. Cancer 67(11):2795–2800
Lawton CA, Fish BL, Moulder JE (1994) Effect of nephrotoxic drugs on the development of radiation nephropathy after bone marrow transplantation. Int J Radiat Oncol Biol Phys 28(4):883–889
Lee WY, Oh ES, Min CK, Kim DW, Lee JW, Kang MI, Min WS, Cha BY, Lee KW, Son HY, Kang SK, Kim CC (2001) Changes in autoimmune thyroid disease following allogeneic bone marrow transplantation. Bone Marrow Transplant 28(1):63–66. doi:10.1038/sj.bmt.1703102
Lee WY, Cho SW, Oh ES, Oh KW, Lee JM, Yoon KH, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim CC (2002) The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab 87(1):329–335
Lee WY, Baek KH, Rhee EJ, Tae HJ, Oh KW, Kang MI, Lee KW, Kim SW, Kim CC, Oh ES (2004) Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation. Bone Marrow Transplant 34(1):89–94. doi:10.1038/sj.bmt.1704535, 1704535 [pii]
Lee JW, Kang HJ, Kim EK, Kim H, Shin HY, Ahn HS (2009) Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children. Bone Marrow Transplant 44(12):793–797
Leiper AD, Stanhope R, Lau T, Grant DB, Blacklock H, Chessells JM, Plowman PN (1987) The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function. Br J Haematol 67(4):419–426
Leung W, Ahn H, Rose SR, Phipps S, Smith T, Gan K, O'Connor M, Hale GA, Kasow KA, Barfield RC, Madden RM, Pui CH (2007) A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. Medicine (Baltimore) 86(4):215–224. doi:10.1097/MD.0b013e31812f864d, 00005792-200707000-00004 [pii]
Lin J, Markowitz GS, Nicolaides M, Hesdorffer CS, Appel GB, D'Agati VD, Savage DG (2001) Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literature. Am J Nephrol 21(5):351–356
Lin SC, Jen YM, Chang YC, Lin CC (2008) Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiotherapy, and validation of the Taiwanese version of the xerostomia questionnaire. J Pain Symptom Manage 36(2):141–148
Llamas P, Romero R, Cabrera R, Sanjuan I, Fores R, Fernandez MN (1997) Management of thrombotic microangiopathy following allogeneic transplantation: what is the role of plasma exchange? Bone Marrow Transplant 20(4):305–306
Lof CM, Winiarski J, Giesecke A, Ljungman P, Forinder U (2009) Health-related quality of life in adult survivors after paediatric allo-SCT. Bone Marrow Transplant 43(6):461–468. doi:10.1038/bmt.2008.338, bmt2008338 [pii]
Lonnerholm G, Carlson K, Bratteby LE, Backlund L, Hagberg H, Rikner G, Smedmyr B, Oberg G, Simonsson B (1991) Renal function after autologous bone marrow transplantation. Bone Marrow Transplant 8(2):129–134
Loren AW, Chow E, Jacobsohn DA, Gilleece M, Halter J, Joshi S, Wang Z, Sobocinski KA, Gupta V, Hale GA, Marks DI, Stadtmauer EA, Apperley J, Cahn JY, Schouten HC, Lazarus HM, Savani BN, McCarthy PL, Jakubowski AA, Kamani NR, Hayes-Lattin B, Maziarz RT, Warwick AB, Sorror ML, Bolwell BJ, Socie G, Wingard JR, Rizzo JD, Majhail NS (2011) Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant 17(2):157–166. doi:10.1016/j.bbmt.2010.07.009, S1083-8791(10)00300-9 [pii]
Lorini R, Cortona L, Scaramuzza A, De Stefano P, Locatelli F, Bonetti F, Severi F (1995) Hyperinsulinemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplant 15(6):873–877
Luo XD, Liu QF, Zhang Y, Sun J, Wang GB, Fan ZP, Yi ZS, Ling YW, Wei YQ, Liu XL, Xu B (2011) Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation: etiology and pathogenesis. Blood Cells Mol Dis 46(2):182–187
Majhail NS, Lazarus HM, Burns LJ (2008) Iron overload in hematopoietic cell transplantation. Bone Marrow Transplant 41(12):997–1003
Majhail NS, Challa TR, Mulrooney DA, Baker KS, Burns LJ (2009) Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 15(9):1100–1107. doi:10.1016/j.bbmt.2009.05.010, S1083-8791(09)00249-3 [pii]
Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A (2012) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant 18(3):348–371. doi:10.1016/j.bbmt.2011.12.519, S1083-8791(11)01081-0 [pii]
Manenti F, Galimberti M, Lucarelli G, Polchi P, De Sanctis V, Tanas R, Vullo C, Ruggiero L (1989) Growth and endocrine function after bone marrow transplantation for thalassemia major. Prog Clin Biol Res 309:273–280
Marazuela M, Steegman JL (2000) Transfer of auto-immune hypothyroidism following bone marrow transplantation from a donor with Graves' disease. Bone Marrow Transplant 26(11):1217–1220. doi:10.1038/sj.bmt.1702676
Markowitz GS, Appel GB, Fine PL, Fenves AZ, Loon NR, Jagannath S, Kuhn JA, Dratch AD, D'Agati VD (2001) Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 12(6):1164–1172
Marr H, McDonald EJ, Merriman E, Smith M, Mangos H, Stoddart C, Ganly P (2009) Successful treatment of transplant-associated microangiopathy with rituximab. N Z Med J 122(1292):72–74
Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254–1259
Martin PJ, Counts GW Jr, Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ, Flowers ME, Syrjala KL, Hansen JA, Storb RF, Storer BE (2010) Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol 28(6):1011–1016. doi:10.1200/JCO.2009.25.6693, JCO.2009.25.6693 [pii]
Mattison GR, Glazer GM, Quint LE, Francis IR, Bree RL, Ensminger WD (1987) MR imaging of hepatic focal nodular hyperplasia: characterization and distinction from primary malignant hepatic tumors. AJR Am J Roentgenol 148(4):711–715
Mawardi H, Elad S, Correa ME, Stevenson K, Woo SB, Almazrooa S, Haddad R, Antin JH, Soiffer R, Treister N (2011) Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes. Bone Marrow Transplant 46(6):884–891
Mayer EI, Dopfer RE, Klingebiel T, Scheel-Walter H, Ranke MB, Niethammer D (1999) Longitudinal gonadal function after bone marrow transplantation for acute lymphoblastic leukemia during childhood. Pediatr Transplant 3(1):38–44
McClune BL, Polgreen LE, Burmeister LA, Blaes AH, Mulrooney DA, Burns LJ, Majhail NS (2011) Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients. Bone Marrow Transplant 46(1):1–9. doi:10.1038/bmt.2010.198, bmt2010198 [pii]
McDonald GB, Sullivan KM, Schuffler MD, Shulman HM, Thomas ED (1981) Esophageal abnormalities in chronic graft-versus-host disease in humans. Gastroenterology 80(5 pt 1):914–921
McDonald GB, Sullivan KM, Plumley TF (1984) Radiographic features of esophageal involvement in chronic graft-vs.-host disease. AJR Am J Roentgenol 142(3):501–506
Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit MEJ, Ruccione K, Smithson WA, Robison LL (2001) Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 19(13):3163–3172
Miceli MH, Dong L, Grazziutti ML, Fassas A, Thertulien R, Van Rhee F, Barlogie B, Anaissie EJ (2006) Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients. Bone Marrow Transplant 37(9):857–864
Michel G, Socie G, Gebhard F, Bernaudin F, Thuret I, Vannier JP, Demeocq F, Leverger G, Pico JL, Rubie H, Mechinaud F, Reiffers J, Gratecos N, Troussard X, Jouet JP, Simonin G, Gluckman E, Maraninchi D (1997) Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation–a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 15(6):2238–2246
Mielcarek M, Martin PJ, Leisenring W, Flowers ME, Maloney DG, Sandmaier BM, Maris MB, Storb R (2003) Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 102(2):756–762
Minocha A, Mandanas RA, Kida M, Jazzar A (1997) Bullous esophagitis due to chronic graft-versus-host disease. Am J Gastroenterol 92(3):529–530
Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347(8):589–600
Mont MA, Carbone JJ, Fairbank AC (1996) Core decompression versus nonoperative management for osteonecrosis of the hip (Review). Clin Orthop Relat Res 324:169–178
Mostoufi-Moab S, Ginsberg JP, Bunin N, Zemel B, Shults J, Leonard MB (2011) Bone density and structure in long-term survivors of pediatric allogeneic hematopoietic stem cell transplantation. J Bone Miner Res. doi:10.1002/jbmr.1499
Nakshabendi IM, Maldonado ME, Coppola D, Mamel JJ (2000) Esophageal cast: a manifestation of graft-versus-host disease. Dig Dis 18(2):103–105
Neofytos D, Ojha A, Mookerjee B, Wagner J, Filicko J, Ferber A, Dessain S, Grosso D, Brunner J, Flomenberg N, Flomenberg P (2007) Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant 13(1):74–81
Ness KK, Bhatia S, Baker KS, Francisco L, Carter A, Forman SJ, Robison LL, Rosenthal J, Gurney JG (2005) Performance limitations and participation restrictions among childhood cancer survivors treated with hematopoietic stem cell transplantation: the bone marrow transplant survivor study. Arch Pediatr Adolesc Med 159(8):706–713. doi:10.1001/archpedi.159.8.706, 159/8/706 [pii]
Ng JS, Lam DS, Li CK, Chik KW, Cheng GP, Yuen PM, Tso MO (1999) Ocular complications of pediatric bone marrow transplantation. Ophthalmology 106(1):160–164
Nicolatou-Galitis O, Kitra V, Van Vliet-Constantinidou C, Peristeri J, Goussetis E, Petropoulos D, Grafakos S (2001) The oral manifestations of chronic graft-versus-host disease (cGVHD) in paediatric allogeneic bone marrow transplant recipients. J Oral Pathol Med 30(3):148–153
Nouri-Majelan N, Sanadgol H, Ghafari A, Rahimian M, Najafi F, Mortazavizadeh M, Moghaddasi S (2005) Antineutrophil cytoplasmic antibody-associated glomerulonephritis in chronic graft-versus-host disease after allogenic hematopoietic stem cell transplantation. Transplant Proc 37(7):3213–3215
Nuver J, Smit AJ, Postma A, Sleijfer DT, Gietema JA (2002) The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev 28(4):195–214
Nysom K, Holm K, Michaelsen KF, Hertz H, Jacobsen N, Muller J, Molgaard C (2000) Bone mass after allogeneic BMT for childhood leukaemia or lymphoma. Bone Marrow Transplant 25(2):191–196
Ogilvy-Stuart AL, Clark DJ, Wallace WH, Gibson BE, Stevens RF, Shalet SM, Donaldson MD (1992) Endocrine deficit after fractionated total body irradiation. Arch Dis Childhood 67(9):1107–1110
Oliveira JS, Bahia D, Franco M, Balda C, Stella S, Kerbauy J (1999) Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal. Bone Marrow Transplant 23(1):99–101
Olivieri NF, Brittenham GM (1997) Iron-chelating therapy and the treatment of thalassemia. Blood 89(3): 739–761
O'Rourke B, Barbir M, Mitchell AG, Yacoub MH, Banner NR (2004) Efficacy and safety of fluvastatin therapy for hypercholesterolemia after heart transplantation: results of a randomised double blind placebo controlled study. Int J Cardiol 94(2–3):235–240
Palmas A, Tefferi A, Myers JL, Scott JP, Swensen SJ, Chen MG, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, Litzow MR (1998) Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 100(4):680–687
Papadimitriou A, Urena M, Hamill G, Stanhope R, Leiper AD (1991) Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation. Arch Dis Childhood 66(6):689–692
Parsons SK, Phipps S, Sung L, Baker KS, Pulsipher MA, Ness KK (2012) NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: health-related quality of life, functional, and neurocognitive outcomes. Biol Blood Marrow Transplant 18(2):162–171. doi:10.1016/j.bbmt.2011.12.501, S1083-8791(11)01063-9 [pii]
Peffault de Latour R, Levy V, Asselah T, Marcellin P, Scieux C, Ades L, Traineau R, Devergie A, Ribaud P, Esperou H, Gluckman E, Valla D, Socie G (2004) Long-term outcome of hepatitis C infection after bone marrow transplantation. Blood 103(5):1618–1624
Perkins JL, Kunin-Batson AS, Youngren NM, Ness KK, Ulrich KJ, Hansen MJ, Petryk A, Steinberger J, Anderson FS, Baker KS (2007) Long-term follow-up of children who underwent hematopoietic cell transplant (HCT) for AML or ALL at less than 3 years of age. Pediatr Blood Cancer 49(7):958–963. doi:10.1002/pbc.21207
Perrotta S, Conte ML, La Manna A, Indolfi P, Rossi F, Locatelli F, Nobili B (2005) Membranous glomerulopathy in children given allogeneic hematopoietic stem cell transplantation. Haematologica 90(Suppl):ECR31
Petryk A, Bergemann TL, Polga KM, Ulrich KJ, Raatz SK, Brown DM, Robison LL, Baker KS (2006) Prospective study of changes in bone mineral density and turnover in children after hematopoietic cell transplantation. J Clin Endocrinol Metab 91(3):899–905. doi:10.1210/jc.2005-1927, jc.2005-1927 [pii]
Phipps S, Dunavant M, Srivastava DK, Bowman L, Mulhern RK (2000) Cognitive and academic functioning in survivors of pediatric bone marrow transplantation. J Clin Oncol 18(5):1004–1011
Poppelreuter M, Weis J, Mumm A, Orth HB, Bartsch HH (2008) Rehabilitation of therapy-related cognitive deficits in patients after hematopoietic stem cell transplantation. Bone Marrow Transplant 41(1):79–90. doi:10.1038/sj.bmt.1705884, 1705884 [pii]
Prasad GV, Ahmed A, Nash MM, Zaltzman JS (2003) Blood pressure reduction with HMG-CoA reductase inhibitors in renal transplant recipients. Kidney Int 63(1):360–364
Prasad PK, Sun CL, Baker KS, Francisco L, Forman S, Bhatia S, Shankar SM (2008) Health care utilization by adult Hispanic long-term survivors of hematopoietic stem cell transplantation: report from the Bone Marrow Transplant Survivor Study. Cancer 113(10):2724–2733. doi:10.1002/cncr.23917
Pritchett JW (2001) Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res 386:173–178
Probert JC, Parker BR (1975) The effects of radiation therapy on bone growth. Radiology 114(1):155–162
Pullarkat V, Blanchard S, Tegtmeier B, Dagis A, Patane K, Ito J, Forman SJ (2008) Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 42(12): 799–805
Pulsipher MA, Skinner R, McDonald GB, Hingorani S, Armenian SH, Cooke KR, Gracia C, Petryk A, Bhatia S, Bunin N, Nieder ML, Dvorak CC, Sung L, Sanders JE, Kurtzberg J, Baker KS (2012) National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: The Need for Pediatric-Specific Long-Term Follow-up Guidelines. Biol Blood Marrow Transplant 18(3):334–347. doi:10.1016/j.bbmt.2012.01.003, S1083-8791(12)00029-8 [pii]
Ramachandran M, Ward K, Brown RR, Munns CF, Cowell CT, Little DG (2007) Intravenous bisphosphonate therapy for traumatic osteonecrosis of the femoral head in adolescents. J Bone Joint Surg Am Vol 89(8):1727–1734
Rao PS (2005) Nephrotic syndrome in patients with peripheral blood stem cell transplant. Am J Kidney Dis 45(4):780–785
Reddy P, Johnson K, Uberti JP, Reynolds C, Silver S, Ayash L, Braun TM, Ratanatharathorn V (2006) Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 38(5):351–357
Reusch JE (2002) Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome. Am J Cardiol 90(5A):19G–26G
Rodgers C, Monroe R (2007) Osteopenia and osteoporosis in pediatric patients after stem cell transplant. J Pediatr Oncol Nurs 24(4):184–189. doi:10.1177/1043454207303942, 24/4/184 [pii]
Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141(3):259–277
Rose C, Ernst O, Hecquet B, Maboudou P, Renom P, Noel MP, Yakoub-Agha I, Bauters F, Jouet JP (2007) Quantification by magnetic resonance imaging and liver consequences of post-transfusional iron overload alone in long term survivors after allogeneic hematopoietic stem cell transplantation (HSCT). Haematologica 92(6):850–853
Rosenberg PS, Socie G, Alter BP, Gluckman E (2005) Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 105(1):67–73
Rourke M, Kazak A (2005) Psychological aspects of long-term survivorship. Survivors of childhood and adolescent cancer: a multidisciplinary approach, 2nd edn. Springer, Heidelberg
Rovelli A, Cohen A, Uderzo C, Dodero P, Brisigotti M, Castellani MR, Romano C (1997) Follicular cell carcinoma of the thyroid in a child after bone marrow transplantation for acute lymphoblastic leukemia. Acta Haematol 97(4):225–227
Roy V, Rizvi MA, Vesely SK, George JN (2001) Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant 27(6):641–646
Ruble K, Hayat MJ, Stewart KJ, Chen AR (2010) Bone mineral density after bone marrow transplantation in childhood: measurement and associations. Biol Blood Marrow Transplant 16(10):1451–1457. doi:10.1016/j.bbmt.2010.04.010, S1083-8791(10)00165-5 [pii]
Ruggenenti P, Noris M, Remuzzi G (2001) Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 60(3):831–846
Sakai M, Ikezoe T, Bandobashi K, Togitani K, Yokoyama A (2010) Successful treatment of transplantation-associated thrombotic microangiopathy with recombinant human soluble thrombomodulin. Bone Marrow Transplant 45(4):803–805
Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Ljungman P, Van Lint MT, Powles R, Jackson G, Hinterberger-Fischer M, Kolb HJ, Apperley JF (2001) Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet 358(9278):271–276, S0140673601054824 [pii]
Sanders JE (1991) Endocrine problems in children after bone marrow transplant for hematologic malignancies. The Long-term follow-up team. Bone Marrow Transplant 8(Suppl 1):2–4
Sanders JE (2008) Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant 41(2):223–227. doi:10.1038/sj.bmt.1705875, 1705875 [pii]
Sanders JE, Flournoy N, Thomas ED, Buckner CD, Lum LG, Clift RA, Appelbaum FR, Sullivan KM, Stewart P, Deeg HJ et al (1985) Marrow transplant experience in children with acute lymphoblastic leukemia: an analysis of factors associated with survival, relapse, and graft-versus-host disease. Med Pediatr Oncol 13(4):165–172
Sanders JE, Pritchard S, Mahoney P, Amos D, Buckner CD, Witherspoon RP, Deeg HJ, Doney KC, Sullivan KM, Appelbaum FR et al (1986) Growth and development following marrow transplantation for leukemia. Blood 68(5):1129–1135
Sanders JE, Buckner CD, Amos D, Levy W, Appelbaum FR, Doney K, Storb R, Sullivan KM, Witherspoon RP, Thomas ED (1988) Ovarian function following marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 6(5):813–818
Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, Doney K, Storb R, Sullivan K, Witherspoon R, Appelbaum FR (1996) Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87(7):3045–3052
Sanders JE, Guthrie KA, Hoffmeister PA, Woolfrey AE, Carpenter PA, Appelbaum FR (2005) Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood 105(3):1348–1354. doi:10.1182/blood-2004-07-2528, 2004-07-2528 [pii]
Sanders JE, Hoffmeister PA, Woolfrey AE, Carpenter PA, Storer BE, Storb RF, Appelbaum FR (2009) Thyroid function following hematopoietic cell transplantation in children: 30 years' experience. Blood 113(2):306–308. doi:10.1182/blood-2008-08-173005, blood-2008-08-173005 [pii]
Sanders JE, Woolfrey AE, Carpenter PA, Storer BE, Hoffmeister PA, Deeg HJ, Flowers ME, Storb RF (2011) Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia. Blood 118(5):1421–1428. doi:10.1182/blood-2011-02-334953, blood-2011-02-334953 [pii]
Sarkodee-Adoo C, Sotirescu D, Sensenbrenner L, Rapoport AP, Cottler-Fox M, Tricot G, Ruehle K, Meisenberg B (2003) Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A. Transfusion 43(1):78–84
Sauleda J, Gea JG, Aguar MC, Aran X, Pasto M, Broquetas JM (1994) Probable pentamidine-induced acute pancreatitis. Ann Pharmacother 28(1):52–53
Schimmer AD, Minden MD, Keating A (2000) Osteoporosis after blood and marrow transplantation: clinical aspects. Biol Blood Marrow Transplant 6(2A):175–181
Schulte CM, Beelen DW (2004) Bone loss following hematopoietic stem cell transplantation: a long-term follow-up. Blood 103(10):3635–3643
Sebastian E, Martin J, McDonald GB, Flores T, Rodriguez A, Blanco A, Vazquez L, de Fuentes I, Caballero MD (2011) Cryptosporidium parvum infection vs GVHD after hematopoietic SCT: diagnosis by PCR with resolution of symptoms. Bone Marrow Transplant 46(4):612–614
Shah AJ, Epport K, Azen C, Killen R, Wilson K, De Clerck D, Crooks G, Kapoor N, Kohn DB, Parkman R, Weinberg KI (2008) Progressive declines in neurocognitive function among survivors of hematopoietic stem cell transplantation for pediatric hematologic malignancies. J Pediatr Hematol Oncol 30(6):411–418. doi:10.1097/MPH.0b013e318168e750
Shalet SM, Gibson B, Swindell R, Pearson D (1987) Effect of spinal irradiation on growth. Arch Dis Childhood 62(5):461–464
Shalitin S, Phillip M, Stein J, Goshen Y, Carmi D, Yaniv I (2006) Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transplant 37(12):1109–1117. doi:10.1038/sj.bmt.1705374, 1705374 [pii]
Shankar SM, Bunin NJ, Moshang T Jr (1996) Growth in children undergoing bone marrow transplantation after busulfan and cyclophosphamide conditioning. J Pediatr Hematol Oncol 18(4):362–366
Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. New Engl J Med 333(20):1301–1307
Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, PsgPSoPitEa R (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360(9346):1623–1630
Shore RE, Woodard E, Hildreth N, Dvoretsky P, Hempelmann L, Pasternack B (1985) Thyroid tumors following thymus irradiation. J Natl Cancer Inst 74(6):1177–1184
Sklar C, Sarafoglou K, Whittam E (1993) Efficacy of insulin-like growth factor binding protein 3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation. Acta Endocrinol (Copenh) 129(6):511–515
Sklar C, Boulad F, Small T, Kernan N (2001) Endocrine complications of pediatric stem cell transplantation. Front Biosci 6:G17–G22
Slatter MA, Gennery AR, Cheetham TD, Bhattacharya A, Crooks BN, Flood TJ, Cant AJ, Abinun M (2004) Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning. Bone Marrow Transplant 33(9):949–953. doi:10.1038/sj.bmt.1704456, 1704456 [pii]
Snover DC, Weisdorf S, Bloomer J, McGlave P, Weisdorf D (1989) Nodular regenerative hyperplasia of the liver following bone marrow transplantation. Hepatology 9(3):443–448
Socie G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB, Sullivan KM, Rowlings PA, Kingma DW, Banks PM, Travis WD, Witherspoon RP, Sanders J, Jaffe ES, Horowitz MM (2000) New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol 18(2):348–357
Som S, Deford CC, Kaiser ML, Terrell DR, Kremer Hovinga JA, Lammle B, George JN, Vesely SK (2012) Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion 52(12):2525–2532
Spinelli S, Chiodi S, Bacigalupo A, Brasca A, Menada MV, Petti AR, Ravera G, Gualandi F, VanLint MT, Sessarego M et al (1994) Ovarian recovery after total body irradiation and allogeneic bone marrow transplantation: long-term follow up of 79 females. Bone Marrow Transplant 14(3):373–380
Stern JM, Sullivan KM, Ott SM, Seidel K, Fink JC, Longton G, Sherrard DJ (2001) Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. Biol Blood Marrow Transplant 7(5):257–264
Stevens AM, Sullivan KM, Nelson JL (2003) Polymyositis as a manifestation of chronic graft-versus-host disease (Review). Rheumatology 42(1):34–39
Stewart BL, Storer B, Storek J, Deeg HJ, Storb R, Hansen JA, Appelbaum FR, Carpenter PA, Sanders JE, Kiem HP, Nash RA, Petersdorf EW, Moravec C, Morton AJ, Anasetti C, Flowers MED, Martin PJ (2004) Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 104(12):3501–3506
Strasser SI, Myerson D, Spurgeon CL, Sullivan KM, Storer B, Schoch HG, Kim S, Flowers ME, McDonald GB (1999a) Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up. Hepatology 29(6):1893–1899
Strasser SI, Sullivan KM, Myerson D, Spurgeon CL, Storer B, Schoch HG, Murakami CS, McDonald GB (1999b) Cirrhosis of the liver in long-term marrow transplant survivors. Blood 93(10):3259–3266
Strippoli GF, Craig M, Deeks JJ, Schena FP, Craig JC (2004) Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review (Review). BMJ 329(7470):828
Stulberg BN, Davis AW, Bauer TW, Levine M, Easley K (1991) Osteonecrosis of the femoral head. A prospective randomized treatment protocol. Clin Orthop Relat Res 268:140–151
Sudour H, Mainard L, Baumann C, Clement L, Salmon A, Bordigoni P (2009) Focal nodular hyperplasia of the liver following hematopoietic SCT. Bone Marrow Transplant 43(2):127–132
Suehiro T, Masutani K, Yokoyama M, Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Katafuchi R, Nagatoshi Y, Hirakata H (2002) Diffuse proliferative glomerulonephritis after bone marrow transplantation. Clin Nephrol 58(3):231–237
Suh DW, Ruttum MS, Stuckenschneider BJ, Mieler WF, Kivlin JD (1999) Ocular findings after bone marrow transplantation in a pediatric population. Ophthalmology 106(8):1564–1570
Syrjala KL, Langer SL, Abrams JR, Storer B, Sanders JE, Flowers ME, Martin PJ (2004) Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 291(19):2335–2343. doi:10.1001/jama.291.19.2335, 291/19/2335 [pii]
Talvensaari K, Knip M (1997) Childhood cancer and later development of the metabolic syndrome. Ann Med 29(5):353–355
Talvensaari KK, Lanning M, Tapanainen P, Knip M (1996) Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab 81(8):3051–3055
Tarbell NJ, Guinan EC, Chin L, Mauch P, Weinstein HJ (1990) Renal insufficiency after total body irradiation for pediatric bone marrow transplantation. Radiother Oncol 18(Suppl 1):139–142
Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M (2000) Impaired glucose tolerance and dyslipidaemia as late effects after bone- marrow transplantation in childhood. Lancet 356(9234):993–997
Taskinen M, Kananen K, Valimaki M, Loyttyniemi E, Hovi L, Saarinen-Pihkala U, Lipsanen-Nyman M (2006) Risk factors for reduced areal bone mineral density in young adults with stem cell transplantation in childhood. Pediatr Transplant 10(1):90–97. doi:10.1111/j.1399-3046.2005.00405.x, PTR405 [pii]
Taskinen M, Saarinen-Pihkala UM, Hovi L, Vettenranta K, Makitie O (2007) Bone health in children and adolescents after allogeneic stem cell transplantation: high prevalence of vertebral compression fractures. Cancer 110(2):442–451. doi:10.1002/cncr.22796
Tatevossian R, Blair JC, Plowman PN, Savage MO, Shankar AG (2004) Thyrotoxicosis after matched unrelated bone marrow transplantation. J Pediatr Hematol Oncol 26(8):529–531
Thibaud E, Rodriguez-Macias K, Trivin C, Esperou H, Michon J, Brauner R (1998) Ovarian function after bone marrow transplantation during childhood. Bone Marrow Transplant 21(3):287–290. doi:10.1038/sj.bmt.1701075
Thomas BC, Stanhope R, Plowman PN, Leiper AD (1993a) Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood. Acta Endocrinol (Copenh) 128(6):508–512
Thomas BC, Stanhope R, Plowman PN, Leiper AD (1993b) Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. Eur J Pediatr 152(11):888–892
Thomas SE, Hutchinson RJ, DebRoy M, Magee JC (2004) Successful renal transplantation following prior bone marrow transplantation in pediatric patients. Pediatr Transplant 8(5):507–512
Tofferi JK, Gilliland W (2006) Avascular necrosis. WebMD: http://www.emedicine.com/med/topic2924.htm
Tolar J, Petryk A, Khan K, Bjoraker KJ, Jessurun J, Dolan M, Kivisto T, Charnas L, Shapiro EG, Orchard PJ (2009) Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease. Bone Marrow Transplant 43(1):21–27. doi:10.1038/bmt.2008.273
Tomonari A, Takahashi S, Takasugi K, Ooi J, Tsukada N, Konuma T, Iseki T, Tojo A, Asano S (2006) Pancreatic hyperamylasemia and hyperlipasemia in association with cytomegalovirus infection following unrelated cord blood transplantation for acute myelogenous leukemia. Int J Hematol 84(5):438–440
Treister NS, Woo SB, O'Holleran EW, Lehmann LE, Parsons SK, Guinan EC (2005) Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11(9):721–731
Treister NS, Cook EF Jr, Antin J, Lee SJ, Soiffer R, Woo SB (2008) Clinical evaluation of oral chronic graft-versus-host disease. Biol Blood Marrow Transplant 14(1):110–115
Trevisan M, Liu J, Bahsas FB, Menotti A (1998) Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol 148(10):958–966
Tsiara S, Elisaf M, Mikhailidis DP (2003) Early vascular benefits of statin therapy (Review). Curr Med Res Opin 19(6):540–556
Uderzo C, van Lint MT, Rovelli A, Weber G, Castellani MR, Bacigalupo A, Masera N, Cohen A (1994) Papillary thyroid carcinoma after total body irradiation. Arch Dis Childhood 71(3):256–258
Uderzo C, Fraschini D, Balduzzi A, Galimberti S, Arrigo C, Biagi E, Pignanelli M, Nicolini B, Rovelli A (1997) Long-term effects of bone marrow transplantation on dental status in children with leukaemia. Bone Marrow Transplant 20(10):865–869
Uderzo C, Fumagalli M, De Lorenzo P, Busca A, Vassallo E, Bonanomi S, Lanino E, Dini G, Varotto S, Messina C, Miniero R, Valsecchi MG, Balduzzi A (2000) Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation. Bone Marrow Transplant 26(9):1005–1009
Valimaki MJ, Kinnunen K, Volin L, Tahtela R, Loyttyniemi E, Laitinen K, Makela P, Keto P, Ruutu T (1999) A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant 23(4):355–361
van Burik JA, Lawatsch EJ, DeFor TE, Weisdorf DJ (2001) Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 7(12):674–679
van Burik JA, Carter SL, Freifeld AG, High KP, Godder KT, Papanicolaou GA, Mendizabal AM, Wagner JE, Yanovich S, Kernan NA (2007) Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease. Biol Blood Marrow Transplant 13(12):1487–1498. doi:10.1016/j.bbmt.2007.08.049, S1083-8791(07)00440-5 [pii]
van der Pas-van Voskuilen IG, Veerkamp JS, Raber-Durlacher JE, Bresters D, van Wijk AJ, Barasch A, McNeal S, Gortzak RA (2009) Long-term adverse effects of hematopoietic stem cell transplantation on dental development in children. Support Care Cancer 17(9):1169–1175
van Kempen-Harteveld ML, Struikmans H, Kal HB, van der Tweel I, Mourits MP, Verdonck LF, Schipper J, Battermann JJ (2000) Cataract-free interval and severity of cataract after total body irradiation and bone marrow transplantation: influence of treatment parameters. Int J Radiat Oncol Biol Phys 48(3):807–815
Van Why SK, Friedman AL, Wei LJ, Hong R (1991) Renal insufficiency after bone marrow transplantation in children. Bone Marrow Transplant 7(5):383–388
Vassal G, Deroussent A, Hartmann O, Challine D, Benhamou E, Valteau-Couanet D, Brugieres L, Kalifa C, Gouyette A, Lemerle J (1990) Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study. Cancer Res 50(19):6203–6207
Versleijen MW, Naber AH, Riksen NP, Wanten GJ, Debruyne FM (2005) Recurrent pancreatitis after trimethoprim-sulfamethoxazole rechallenge. Neth J Med 63(7):275–277
Vincent F, Costa MA, Rondeau E (2003) Chronic renal failure: a nonmalignant late effect of allogeneic stem cell transplantation (Letter to the Editor). Blood 102(7):2695–2696
Wang GJ, Cui Q, Balian G (2000) The Nicolas Andry award. The pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop Relat Res 370:295–310
Ward LM, Petryk A, Gordon CM (2009) Use of bisphosphonates in the treatment of pediatric osteoporosis. Int J Clin Rheumatol 4(6):657–672
Wasilewski-Masker K, Kaste SC, Hudson MM, Esiashvili N, Mattano LA, Meacham LR (2008) Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature. Pediatrics 121(3):e705–e713. doi:10.1542/peds.2007-1396, 121/3/e705 [pii]
Weilbaecher KN (2000) Mechanisms of osteoporosis after hematopoietic cell transplantation. Biol Blood Marrow Transplant 6(2A):165–174
Wingard JR, Plotnick LP, Freemer CS, Zahurak M, Piantadosi S, Miller DF, Vriesendorp HM, Yeager AM, Santos GW (1992) Growth in children after bone marrow transplantation: busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation. Blood 79(4):1068–1073
Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106(4):1460–1465
World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129
Yokota A, Ozawa S, Masanori T, Akiyama H, Ohshima K, Kanda Y, Takahashi S, Mori T, Nakaseko C, Onoda M, Kishi K, Doki N, Aotsuka N, Kanamori H, Maruta A, Sakamaki H, Okamoto S (2012) Secondary solid tumors after allogeneic hematopoietic SCT in Japan. Bone Marrow Transplant 47(1):95–100
Zou S, Stramer SL, Dodd RY (2012) Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations. Transfus Med Rev 26(2):119–128
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Baker, K.S., Petryk, A., Fisher, V.L., Duncan, C., Carpenter, P.A. (2014). Late Effects in Survivors After Hematopoietic Cell Transplantation in Childhood. In: Smith, F., Reaman, G., Racadio, J. (eds) Hematopoietic Cell Transplantation in Children with Cancer. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39920-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-39920-6_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-39919-0
Online ISBN: 978-3-642-39920-6
eBook Packages: MedicineMedicine (R0)